Symbol of the Government of Canada

Common menu bar links

Canada's Research-Based Pharmaceutical Companies (Rx&D)

Submission — Canada's Research-Based Pharmaceutical Companies (Rx&D)

Important note: The content of submissions and summaries is the sole responsibility of the person and / or organization having made a submission. The posting of this content does not indicate that the Panel supports or endorses it. Submissions and summaries are posted in the language provided without modification.

Submitter(s): Sampson, Stephen

Summary: For our sector, ensuring healthy global competitiveness and attracting R&D investments to this country is ultimately less about direct financial incentives and more about the policy framework within Canadian jurisdictions, both Federal and Provincial. Our industry wants to attract higher levels of global investment capital for the Canadian Life Sciences sector as opposed to higher levels of Government financial support. In the current fiscal environment, this approach has the advantage of not depending on Government finances – it is rather a matter of leadership and will.

Full submission: PDF Version